Shameek Konar - 27 Dec 2023 Form 3 Insider Report for Comera Life Sciences Holdings, Inc.

Reporting relationship: Member of 10% owner group
Issuer ticker: N/A
Reported as of: 27 Dec 2023
Net transaction value: $0
SEC form: 3
Accepted by SEC: 02 Feb 2024, 19:47:03 UTC
Prior SEC filing: 05 Jun 2023
Next SEC filing: 02 Feb 2024
Source filing: View source filing
Reporting owner signature: /s/ Shameek Konar

Key filing fact

Shameek Konar filed Form 3 for Comera Life Sciences Holdings, Inc. on 02 Feb 2024.

Key facts

This page summarizes Shameek Konar's Form 3 filing for Comera Life Sciences Holdings, Inc..
0 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 02 Feb 2024, 19:47.

Change

Previous filing in this sequence was filed on 05 Jun 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CMRA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,001,064
Date: 27 Dec 2023
Ownership: By Regolith Capital Investments, L.P.
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CMRA holding Derivative

Warrants to Purchase Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 27 Dec 2023
Ownership: By Regolith Capital Investments, L.P.
Underlying class: Common Stock
Underlying amount: 1,198,044
Exercise price: $0.6135
Footnotes: F1

CMRA holding Derivative

Warrants to Purchase Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 27 Dec 2023
Ownership: By Regolith Capital Investments, L.P.
Underlying class: Common Stock
Underlying amount: 513,447
Exercise price: $0.6135
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The reporting persons are general partners of Regolith Capital Investments, L.P. ("Regolith") and disclaim beneficial ownership of the securities held by Regolith except to the extent of their pecuniary interest therein